Hamlet BioPharma AB
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
HAMLET | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0015661145 (+2 more)
- LEI:
- 549300HJV2LJY4CDBR64
- Country:
- Sweden
- Address:
- Klinikgatan 32, 222 42 LUND
- Website:
- https://hamletbiopharma.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Hamlet BioPharma AB is a clinical-stage pharmaceutical company developing novel therapies for cancer and infections. Its lead oncology candidate, Alpha1H, is a tumor-killing protein-lipid complex designed to selectively target and eliminate tumor cells while sparing healthy tissue. Alpha1H has successfully completed Phase II trials for bladder cancer, demonstrating significant tumor reduction and immune system activation. The company is also advancing immunotherapy as an alternative to antibiotics. Its IL-1 inhibitor, anakinra, has completed Phase II studies showing positive results in treating patients with recurrent urinary tract infections and Bladder Pain Syndrome (interstitial cystitis). Hamlet BioPharma's pipeline focuses on creating highly specific treatments with improved safety profiles for significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Hamlet BioPharma AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hamlet BioPharma AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hamlet BioPharma AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
